Custom Phenotypic Assay Development at PhenoVista Biosciences

Anthony Essex, PhD, Chief Scientific Officer at PhenoVista Biosciences, discusses assay development for high content screening. Learn how PhenoVista's custom iPSC neuronal and T-cell-endothelial assays are more physiologically relevant for enhanced phenotypic screening.